1977
DOI: 10.1002/hlca.19770600105
|View full text |Cite
|
Sign up to set email alerts
|

Totalsynthese von Humaninsulin. IV. Beschreibung der Endstufen

Abstract: Total synthesis of human insulin. IV. Description of the final steps. SummaryRecently a preliminary account was given of a new synthetic pathway leading to human insulin. In the present report the last steps of this synthesis -i.e. as from the unsymmetrical cystine derivative I -are described in detail. I contains the sequences A(14-21) and B(17-30), linked by the disulfide bridge A20-B19. These last steps are : 1) selective removal by pH-controlled acidolysis in trifluoroethanol of N(K)-Trt from leucine B17, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
36
0

Year Published

1978
1978
2011
2011

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 104 publications
(36 citation statements)
references
References 27 publications
0
36
0
Order By: Relevance
“…After 24 h at 37"C, the peptide was first purified by gel filtration on Sephadex G-50-sf in 1 M acetic acid followed by preparative HPLC (yield 20.5 mg, 26.5 %). The third disulfide bond was formed by oxidative removal of the Acm groups with iodine using the method of Sieber et al [18]. Acm-protected bombyxin (20.5 mg) dissolved in 20.5 ml 50% acetic acid was added to a stirring solution of 5.6 ml acetic acid, 6.9 ml 50 mM iodine in acetic acid, and 45 pl 6 M HCI.…”
Section: Methods Hplcmentioning
confidence: 99%
“…After 24 h at 37"C, the peptide was first purified by gel filtration on Sephadex G-50-sf in 1 M acetic acid followed by preparative HPLC (yield 20.5 mg, 26.5 %). The third disulfide bond was formed by oxidative removal of the Acm groups with iodine using the method of Sieber et al [18]. Acm-protected bombyxin (20.5 mg) dissolved in 20.5 ml 50% acetic acid was added to a stirring solution of 5.6 ml acetic acid, 6.9 ml 50 mM iodine in acetic acid, and 45 pl 6 M HCI.…”
Section: Methods Hplcmentioning
confidence: 99%
“…A fundamentally new approach pioneered by Sieber and coworkers [17][18][19] specifically addressed the low disulfide combination yield (Figure 2). They employed a stepwise assembly of the disulfides with initial assembly of the Cys A20-CysB19 linked heterodimer fragment A(14-21):B (17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30).…”
Section: Total Synthesismentioning
confidence: 99%
“…The main limitations of this synthetic approach were the complicated protecting group scheme as well as the observed racemization in the formation of the B16-17 peptide bond. 19 This approach, however, was sufficiently versatile to permit synthesis of a series of analogs at milligram scale. 20,21 Of particular importance was the synthesis of two nonnative monomeric disulfide isomers: [CysA7-CysA11, CysA6-CysB7] and [CysA6-CysA7, CysA11-CysB7] human insulin where the native C-terminal disulfide is maintained.…”
Section: Total Synthesismentioning
confidence: 99%
“…The rat relaxin intermediate contains Acm-, N(in)formyl-and S-sulfoxide-protecting groups and was obtained in yields of 10.1 mg (1.3 pmol) for rat relaxin, 8.3 mg (1.1 pmol) for [B14D]rat relaxin and 11.1 mg (1.5 pmol) for [B14D, BISL, B16VIrat relaxin. The third disulfide bond was synthesized by direct oxidation of the Cys(Acm) group with iodine in aqueous acetic acid following the protocol of Sieber et al [21]. After HPLC purification, rat relaxin, protected in the side chains of tryptophan and methionine, was obtained at a yield of 2.71 mg (0.37 pmol).…”
Section: Methodsmentioning
confidence: 99%